Stueven, A.K.; Kayser, A.; Wetz, C.; Amthauer, H.; Wree, A.; Tacke, F.; Wiedenmann, B.; Roderburg, C.; Jann, H.
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future. Int. J. Mol. Sci. 2019, 20, 3049.
https://doi.org/10.3390/ijms20123049
AMA Style
Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H.
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future. International Journal of Molecular Sciences. 2019; 20(12):3049.
https://doi.org/10.3390/ijms20123049
Chicago/Turabian Style
Stueven, Anna Kathrin, Antonin Kayser, Christoph Wetz, Holger Amthauer, Alexander Wree, Frank Tacke, Bertram Wiedenmann, Christoph Roderburg, and Henning Jann.
2019. "Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future" International Journal of Molecular Sciences 20, no. 12: 3049.
https://doi.org/10.3390/ijms20123049
APA Style
Stueven, A. K., Kayser, A., Wetz, C., Amthauer, H., Wree, A., Tacke, F., Wiedenmann, B., Roderburg, C., & Jann, H.
(2019). Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future. International Journal of Molecular Sciences, 20(12), 3049.
https://doi.org/10.3390/ijms20123049